CTRL + SPACE for auto-complete. The institutional investor bought 14.1 thousand shares of the stock in a transaction took place on 9/30/2020. In the case of Arcturus Therapeutics Holdings Inc., the RSI reading has hit 61.75 for 14-Day. In another most recent transaction, which held on 9/30/2020, SIMPLEX TRADING LLC bought approximately 8.9 thousand shares of PDC Energy Inc. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) went up by 2.99% from its latest closing price compared to the recent 1-year high of $66.24. Positive Prospects, But Probably: Exxon Mobil Corporation (XOM), Plug Power Inc. (PLUG), EPS Surprise As An Investment Strategy: Banco Bilbao Vizcaya Argentaria S.A. (BBVA), Surface Oncology Inc. (SURF), An Unsustainable Story, The Stocks Should Be Avoided? According to WSJ, PDC Energy Inc. (PDCE) obtained an estimated Buy proposal from the 18 brokerage firms currently keeping a deep eye on the stock performance as compares to its rivals. The consensus among analysts is that Arcturus Therapeutics Holdings Inc. (ARCT) is a Buy stock at the moment, with a recommendation rating of 1.8. FIRST CITIZENS BANK & TRUST CO. bought a fresh place in PDC Energy Inc. (NASDAQ:PDCE). Home Finance Entering Stage Of Growth And Momentum: PDC Energy Inc. (PDCE), Arcturus Therapeutics... Finance; Entering Stage Of Growth And Momentum: PDC Energy Inc. (PDCE), Arcturus Therapeutics Holdings Inc. (ARCT) By. The company, currently valued at $1.35 Billion, closed the last trade at $55.13 per share which meant it gained $0.41 on the day or 0.75% during that session. Other than that, the company has, however, increased its growth outlook for the 2020 fiscal year revenue. IA "Marketing Sentinel" seeks to provide the news and analytical information to both American and foreign audiences, events and events in the USA and all over the world reliably, objectively and promptly. In a separate transaction which took place on 9/30/2020, the institutional investor, ENVESTNET ASSET MANAGEMENT, INC. bought 5.6 thousand shares of the company’s stock. The company’s shares have gained +205.26% over the past 6 months, with this year growth rate of -0.93%, compared to 14% for the industry. The total Institutional investors and hedge funds own 83.44% of the company’s stock. Our team comprises Analysts and writers with the knowledge and expertise of Stock Markets and other sectors of Finance. Write CSS OR LESS and hit save. EPS growth is a percentage change in standardized earnings per share over the trailing-twelve-month period to the current year-end. Year-to-date, Arcturus Therapeutics Holdings Inc. shares have moved 407.18%, while the 5-day performance has seen it change 7.84%.